|Day Low/High||237.39 / 240.34|
|52 Wk Low/High||139.64 / 241.82|
If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.
Keep a tally that summarizes all your related holdings: stock, calls and puts.
Shares of heart valve maker Edwards Lifesciences are cheap and out of favor, making this a great opportunity to buy stock in a best of breed company.
The company is a steady grower, but its stock has swooned.
It guides to a very weak third quarter. Apple (AAPL) met earnings expectations but guides to a very weak third quarter. The gross margin projection for both the recently reported period and the third quarter of 2013 likely plays into the bears' conc...
Portfolio Mgr. David Peltier analyzes one of the early low-dollar winners of 2013.
Portfolio Mgr. David Peltier analyzes a low-dollar stock on the verge of a potential turnaround.
Dr. Mark Bussard, Healthcare Analyst at T Rowe Price, names his favorite healthcare stocks for 2013 including Gilead and Edwards Lifesciences.
Volume remains light and leadership is scarce, two things that traders do not like to see.